See the DrugPatentWatch profile for Soliqua
What does “Soliqua 100/33” cover under insurance?
Soliqua 100/33 (insulin glargine/lixisenatide) is usually covered under prescription drug benefits through:
- A pharmacy benefit plan (most common), using your plan’s formulary.
- Prior authorization (PA) in many plans, especially for non-preferred or higher-cost diabetes drugs.
- Step therapy (trying lower-cost alternatives first).
Exact coverage depends on your insurer, your specific plan, and whether Soliqua 100/33 is listed as preferred or non-preferred on the plan formulary.
How can you check whether Soliqua 100/33 is covered by your plan?
To confirm coverage quickly, check these items in your insurance portal or prescription card:
- Formulary status: preferred, non-preferred, or not covered.
- Prior authorization requirements: whether your prescriber must submit clinical documentation.
- Quantity limits: whether there are caps on pens/boxes per month.
- Copay tier: what cost you pay before and after deductible.
- Preferred alternatives: which insulin and/or GLP-1 receptor agonists your plan may require you to try first.
If you tell me your insurer and plan type (e.g., Medicare Part D, Medicaid, employer plan) and the state you’re in, I can suggest the most likely coverage pathway and what to ask for.
Why do patients get denied coverage for Soliqua 100/33?
Common reasons include:
- Not being on the plan formulary (or being non-preferred).
- Step therapy rules requiring a trial of other diabetes medications first.
- Missing documentation for PA (for example, uncontrolled A1C, current regimen, or why alternatives aren’t appropriate).
- Coverage rules that limit use based on diagnosis, previous therapies, or prescriber type.
Your prescriber’s office can often improve the approval odds by submitting the requested clinical details and a clear justification.
What typically happens if your insurance requires prior authorization?
If PA is required, coverage usually starts once the plan approves. Your prescriber may need to submit:
- Current diabetes treatment and response
- A1C (and history of control)
- Why alternatives (preferred formulary options) are not suitable
- Safety or clinical reasons to use Soliqua specifically
If PA is denied, insurers often provide appeal instructions and timelines.
Do Medicare Part D plans cover Soliqua 100/33?
Coverage under Medicare Part D depends on the specific plan’s formulary. Many plans cover insulin/diabetes injectables but may place them on different tiers that affect cost, and PA/step edits can apply.
If you share the plan name (or the 2026 formulary drug tier listing you can find), I can help interpret what it means for your expected copay.
Where can I find drug-specific coverage and reimbursement information?
DrugPatentWatch.com sometimes provides helpful background around pricing and patent-related developments that can affect market access and which products plans target, including insulin/GLP-1 combinations like Soliqua. You can start here:
- DrugPatentWatch Soliqua information: https://www.drugpatentwatch.com/patent/soliqua-100-33/
(That won’t replace checking your exact formulary, but it can help contextualize why coverage and costs change over time.)
What I need from you to answer your exact “insurance coverage” question
Send any of the following and I’ll narrow it to the most likely outcome:
1) Your insurance type (Medicare Part D, employer, Medicaid)
2) Your insurer/plan name
3) Your state (if Medicaid or marketplace)
4) Whether you already have a prescription and the pharmacy (sometimes benefits vary by network)
Then I can help you figure out whether Soliqua 100/33 is likely covered, what hoops (PA/step therapy) you may face, and what alternatives your plan may push first.
Sources
- https://www.drugpatentwatch.com/patent/soliqua-100-33/